Pharmacological evidence of specific acetylcholine transport in rat cerebral cortex and other brain regions

Journal of Neurochemistry

Volumn 139, Issue 4, 2016, Pages 566-575

  Muramatsu, Ikunobu ^a,b,c   Yoshiki, Hatsumi ^b   Uwada, Junsuke ^d   Masuoka, Takayoshi ^a   Sada, Kiyonao ^b   Taniguchi, Takanobu ^d   Nishio, Matomo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c Kimura Hospital   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

ACh esterase; ACh uptake; choline uptake; cholinergic transmission; drugs for Alzheimer's disease; rat brain

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ATROPINE; CARBACHOL; CHOLINE; CHOLINERGIC RECEPTOR; CLONIDINE; CORTICOSTERONE; DECYNIUM 22; DIPHENHYDRAMINE; DONEPEZIL; DYFLOS; GALANTAMINE; HEMICHOLINIUM 3; NEOSTIGMINE; ORGANIC COMPOUND; QUINIDINE; RIVASTIGMINE; SPERMINE; TETRODOTOXIN; TETRYLAMMONIUM; UNCLASSIFIED DRUG; CHOLINESTERASE INHIBITOR;

AMINE TRANSPORT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM CORTEX; CHOLINERGIC TRANSMISSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TEMPERATURE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN CORTEX; COLON; DOSE RESPONSE; DRUG EFFECTS; HEART; KIDNEY; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; ISOFLUROPHATE; KIDNEY; MALE; RATS; RATS, WISTAR;

EID: 84991080355     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13843     Document Type: Article

References (40)

1. Amphoux A., Vialou V., Drescher E., Bruss M., Mannoury L. C. C., Rochat C., Millan M. J., Giros B., Bonisch H. and Gautron S. (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacol. 50, 941–952.
2. Anand R., Gill K. D. and Mahdi A. A. (2014) Therapeutics of Alzheimer's disease: past, present and future. Neuropharmacol. 76, 27–50.
3. Anisuzzaman A. S. M., Nishimune A., Yoshiki H., Uwada J. and Muramatsu I. (2011) Influence of tissue integrity of pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex. J. Pharmacol. Exp. Ther. 339, 186–193.
4. Anisuzzaman A. M. S., Uwada J., Masuoka T. et al. (2013) Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus. J. Neurochem. 126, 360–371.
5. Apparsundaram S., Ferguson S. M., George A. L. and Blakely R. D. (2000) Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem. Biophys. Res. Commun. 276, 862–867.
6. Boivin B., Lavoie C., Vaniotis G., Baragli A., Villeneuve L. R., Ethier N., Trieu P., Allen B. G. and Hebert T. E. (2006) Functional beta-adrenergic receptor signaling on nuclear membranes in adult rat and muse ventricular cardiomyocytes. Cardiovasc. Res. 71, 69–78.
7. Boivin B., Vaniotis G., Allen B. G. and Hebert T. E. (2008) G protein coupled receptors in and on the cell nucleus: a new signaling paradigm? J. Recept. Signal Transduct. Res. 28, 15–28.
8. den Boon F. S., Chameau P., Schaafsma-Zhao Q. et al. (2012) Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc. Natl Acad. Sci. USA 109, 3534–3539.
9. Everitt B. J. and Robbins T. W. (1997) Central cholinergic systems and cognition. Annu. Rev. Psychol. 48, 649–684.
10. Fujita T., Shimada A., Okada N. and Yamamto A. (2006) Functional characterization of Na+-independent choline transport in primary culture of neurons from mouse cerebral cortex. Neurosci. Lett. 393, 216–221.
11. 3H]choline high-affinity uptake in rat striatal synaptosomes. Mol. Pharmacol. 9, 630–639.
12. Haga T. and Noda H. (1973) Choline uptake of rat brain synaptosomes. Biochim. Biophys. Acta 291, 564–575.
13. Hayer-Zillgen M., Bruss M. and Bonish H. (2002) Expression and pharmacological profile of the human organic transporters hOCT1, hOCT2 and gOCT3. Br. J. Pharmacol. 136, 829–836.
14. Inazu M., Takeda H. and Matsumiya T. (2005) Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J. Neurochem. 94, 1427–1437.
15. Jong Y. J., Kumar V. and O'Malley K. L. (2009) Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts. J. Biol. Chem. 284, 35827–35838.
16. Katz H. S., Salehmoghaddam S. and Collier B. (1973) The accumulation of radioactive acetylcholine by a sympathetic ganglion and by brain: failure to label endogenous stores. J. Neurochem. 20, 569–579.
17. Koepsell H. and Endou H. (2004) The SLC22 drug transporter family. Pflugers Arch. 447, 666–676.
18. Koepsell H., Lips K. and Volk C. (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharmaceutical Res. 24, 1227–1251.
19. Kuhar M. J. and Simon J. R. (1974) Acetylcholine uptake: lack of association with cholinergic neurons. J. Neurochem. 22, 1135–1137.
20. Lee N. Y., Choi H. M. and Kang Y. S. (2009a) Choline transport via transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT. Placenta 30, 368–374.
21. Lee W. K., Wolf N. A. and Thevenod F. (2009b) Organic cation transporters: physiology, toxicology and special focus on ethidium as a novel substrate. Curr. Drug Metab. 10, 617–631.
22. Liang C. C. and Quastel J. H. (1969) Effects of drugs on the uptake of acetylcholine in rat brain cortex slices. Biochem. Pharmacol. 18, 1187–1194.
23. Lykhmus O., Gergalova G., Koval L. et al. (2014) Mitochondria express several nicotinic acetylcholine receptor subtypes to control various pathways of apoptosis induction. Int. J. Biochem. Cell Biol. 53, 246–252.
24. Muramatsu I., Tanaka T., Suzuki F., Li Z., Hiraizumi-Hiraoka Y., Anisuzzaman A. S. M., Yamamoto H., Horinouchi T. and Morishima S. (2005) Quantifying receptor properties: the tissue segment binding method – a powerful tool for the pharmacome analysis of native receptors. J. Pharmacol. Sci. 98, 331–339.
25. Muramatsu I., Yoshiki H., Sada K., Uwada J., Taniguchi T., Masuoka T. and Nishio M., (2015) Binding method for detection of muscarinic receptor's natural environment, in Muscarinic Receptor: From Structure to Animal Models (Myslivecek J. and Jakubik J., eds), pp. 69–81. Neuromethods Vol 107: Humana Press, New York.
26. Nakata T., Matsui T., Kobayashi K., Kobayashi Y. and Anzai N. (2013) Organic cation transporter 2 (SLC22A2), a low affinity and high-capacity choline transporter, is preferentially enriched on synaptic vesicles in cholinergic neurons. Neurosci 252, 212–221.
27. Okuda T., Haga T., Kanai Y., Endou H., Ishihara T. and Kasura I. (2000) Identification and characterization of the high-affinity choline transporter. Nat. Neurosci. 3, 120–125.
28. Okuda T., Osawa C., Yamada H., Hayashi K., Nishikawa S., Ushio T., Kubo Y., Satou M., Ogawa H. and Haga T. (2012) Transmembrane topology and oligomeric structure of the high-affinity choline transporter. J. Biol. Chem. 287, 42826–42834.
29. 2+ changes in heterologous cell types and neurons. J. Biol. Chem. 278, 28210–28219.
30. O'Regan S., Traiffort E., Ruat M., Cha N., Compaore D. and Meunier F. M. (2000) An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transport-like proteins. Proc. Natl Acad. Sci. USA 97, 1835–1840.
31. Parsons S. M., Prior C. and Marshall I. G. (1993) Acetylcholine transport, storage and release, in International Review of Neurobiology (Bradley R. J. and Harris R. A., eds), Vol 35, pp. 279–390, Academic Press, New York
32. Pochini L., Scalise M., Galluccio M., Pani G., Siminovitch K. A. and Indiveri C. (2012) The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease. Biochim. Biophys. Acta 1818, 559–565.
33. Polak R. L. and Meeuws M. M. (1966) The influence of atropine on the release and uptake of acetylcholine by isolated cerebral cortex of the rat. Biochem. Pharmacol. 15, 989–992.
34. Schomig E., Lazar A. and Grundemann D. (2006) Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Handb. Exp. Pharmacol. 175, 151–180.
35. Traiffort E., Ruat M., O'Regan S. and Meunier F. M. (2005) Molecular characterization of the family of choline transporter-like proteins and their splice variants. J. Neurochem. 92, 1116–1125.
36. 1-muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells. J. Neurochem. 118, 958–967.
37. Uwada J., Yoshiki H., Masuoka T., Nishio M. and Muramatsu I. (2014) Intracellular localization of M1 muscarinic acetylcholine receptor through clathrin-dependent constitutive internalization via a C-terminal tryptophan-based motif. J. Cell Sci. 127, 3131–3140.
38. Varoqui H. and Erickson J. D. (1996) Active transport of acetylcholine by human vesicular acetylcholine transporter. J. Biol. Chem. 271, 27229–27232.
39. Wess J., Eglen R. M. and Gautam D. (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat. Rev. Drug. Discov. 6, 721–733.
40. Yoshiki H., Uwada J., Anisuzzaman A. S. M., Umada H., Hayashi R., Kainoh M., Masuoka T., Nishio M. and Muramatsu I. (2014) Pharmacologically distinct phenotypes of α1B-adrenoceptors: variation in binding and functional affinities for antagonists. Br. J. Pharmacol. 171, 4890–4901.